Cargando…
Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool
Neoadjuvant endocrine therapy has been increasingly employed in clinical practice to improve surgical options for postmenopausal women with bulky hormone receptor-positive breast cancer. Recent studies indicate that tumour response in this setting may predict long-term outcome of patients on adjuvan...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966629/ https://www.ncbi.nlm.nih.gov/pubmed/20700118 http://dx.doi.org/10.1038/sj.bjc.6605845 |